Corrigendum to “Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology” [Heliyon Volume 9, Issue 8, August 2023, Article e18530]

Gelijkaardige items

• Corrigendum to “Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology” [Heliyon Volume 9, Issue 8, August 2023, Article e18530]
  door: Nalaka Wijekoon, et al.
  Gepubliceerd in: (2025-04-01)
• Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets
  door: Nalaka Wijekoon, et al.
  Gepubliceerd in: (2025-01-01)
• Title-molecular diagnostics of dystrophinopathies in Sri Lanka towards phenotype predictions: an insight from a South Asian resource limited setting
  door: Nalaka Wijekoon, et al.
  Gepubliceerd in: (2024-01-01)
• Thiosemicarbazones down-regulate N-Myc expression in neuroblastoma cells via transcriptional and post-translational mechanisms
  door: Zhao Deng, et al.
  Gepubliceerd in: (2025-11-01)
• Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy
  door: Amel Saoudi, et al.
  Gepubliceerd in: (2024-12-01)